Skip to main content
Log in

A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions

  • Review
  • Antineoplastic Drugs, Multiple Drug Infusion
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

It is important that the stability of reconstituted parenteral antineoplastic agents be established, particularly in the context of ambulatory infusion systems for delivery. The stability of selected agents within each of the five classes of compounds (antimetabolites, alkylating agents, antibiotics, alkaloids and glycosides, and metals) is reviewed from the literature together with additional data from studies carried out using high-performance liquid chromatographic (HPLC) technology in clinically applicable volumes and concentrations for ambulatory infusion. The stability of reconstituted drugs varies from a few minutes (mecloethamine) to many months (FU). Compatibility data on two- and three-drug admixtures of cytotoxic agents are reported for a number of common multidrug regimens. Tabular presentation of the drug-drug compatibilities and incompatibilities is included along with a discussion of the mechanisms for drug-drug interaction. The use of a broad spectrum of compatible cytotoxic drugs is possible, including fluoropyrimidine-, anthracycline-, and platinum-based combinations, providing the capability of carrying out multidrug infusions for 4–7 days in an ambulatory delivery system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CBP:

carboplatin

CDDP:

cisplatin

CP:

cyclophosphamide

DTC:

decarbazine

DX:

doxorubicin

D5W:

dextrose for injection

FU:

fluorouracil

FUDR:

floxuridine

IF:

ifosfamide

LV:

leucovorin

MMC:

mitomycin C

MTX:

methotrexate

NS:

sodium chloride for injection

R:

Ringer's injection

SW:

sterile water

VP16:

etoposide

References

  1. Adams PS, Haines-Nutt RF, Bradford E, Palmer A, Rowland CB (1987) Pharmaceutical aspects of home infusion therapy for cancer patients. Pharm J April 11: 476–478

    Google Scholar 

  2. Allsopp M, Sewell GJ, Rowland C, Riley CM, Schowen RL (1991) The degradation of carboplatin in aqueous solutions containing chloride or other nucleophiles. Int J Pharm 69: 197–210

    Google Scholar 

  3. Anderson N, Lokich J, Bern M, Wallach S, Moore C, Williams D (1989) A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Cancer 63:233–237

    Google Scholar 

  4. Anderson N, Lokich J, Bern M, Wallach S, Moore C, Williams D, Umprayn V (1989) Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. Cancer 63:825–827

    Google Scholar 

  5. Bayoni SM, Al-Badr AA (1989) Fluorouracil. In: Florey K (ed) Analytical profiles of drug substances, vol 18. Academic Press, New York, pp 599–639

    Google Scholar 

  6. Behme RJ, Brooke D, Kensler TT, Scott JA (1988) Incompatibility of ifosfamide with benzyl alcohol preserved bacteriostatic water for injection. Am J Hosp Pharm 45: 627–628

    Google Scholar 

  7. Beijnen JH, Rosing H, Vries PA de, Underberg WJM (1985) Stability of anthracycline antitumor agents in infusion fluids. J Parenter Sci Technol 39: 220–222

    Google Scholar 

  8. Beijnen JH, Houwen OAGJ van der, Underberg WJM (1986) Aspects of the degradation kinetics of doxorubicin in aqueous solution. Int J Pharm 32: 123–131

    Google Scholar 

  9. Beijnen JH, Houwen OAGJ van der, Voskuilen MCH, Underberg WJM (1986) Aspects of the degradation kinetics of daunorubicin in aqueous solution. Int J Pharm 31: 75–82

    Google Scholar 

  10. Beijnen JH, Lingeman H, Van Munster HA, Underberg WJM (1986) Mitomycin antitumour agents: a review of their physico-chemical and analytical properties and stability. J Pharm Biomed Anal 4: 275–295

    Google Scholar 

  11. Beijnen JH, Neef C, Meuwissen OJAT, Rutten JMH, Rosing H, Underberg WJM (1986) Stability of intravenous mixtures of doxorubicin and vincristine. Am J Hosp Pharm 43: 3022–3026

    Google Scholar 

  12. Beijnen JH, Bult A, Underberg WJM (1987) Mitomycin C. In: Florey K (ed) Analytical profiles of drug substances, vol 16. Academic Press. New York, pp 361–401

    Google Scholar 

  13. Beijnen JH, Bult A, Underberg WJM (1988) Mitoxanthrone hydrochloride. In: Florey K (ed) Analytical profiles of drug substances, vol 17. Academic Press, New York, pp 221–258

    Google Scholar 

  14. Beijnen JHM, Vendrig DEMM, Underberg WJM (1988) Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids. J Parenter Sci Technol 43: 84–87

    Google Scholar 

  15. Beijnen JH, Holthuis JJM, Kerkdijk HG, Paalman ACA, Bult A, Underberg WJM (1988) Degradation kinetics of etoposide in aqueous solution. Int J Pharm 41: 169–178

    Google Scholar 

  16. Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL (1981) Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 38: 1914–1918

    Google Scholar 

  17. Benvenuto JA, Adams SC, Vyas HM, Anderson RW (1987) Pharmaceutical issues in infusion chemotherapy stability and compatibility. In: Lokich J (ed) Cancer chemotherapy by infusion, 1st edn. Precept, Chicago, pp 100–113

    Google Scholar 

  18. Bosanquet AG (1986) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays: Adriamycin and other antitumour antibiotics. Cancer Chemother Pharmacol 17: 1–10

    Google Scholar 

  19. Brooke D, Bequette RJ, Davis RE (1973) Chemical stability of cyclophosphamide in parenteral solutions. Am J Hosp Pharm 30: 134–137

    Google Scholar 

  20. Carter SK, Crooke ST (1979) Mitomycin C: current status and new developments. Academic Press, New York

    Google Scholar 

  21. Cheung Y-W, Cradock JC, Vishnuvajjala BR, Flora KP (1987) Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions. Am J Hosp Pharm 44: 124–130

    Google Scholar 

  22. Connors KA, Amidon GL, Stella VJ (1986) Chemical stability of pharmaceuticals: a handbook for pharmacists, 2nd edn. J Wiley & Sons New York

    Google Scholar 

  23. Dine T, Luyckx M, Cazin JC, Buenet C, Cazin M, Goudaliez F, Mallevais ML (1991) Stability and compatibility of vinblastine, vincristine, vindesine, and vinorelbine with PVC infusion bags. Int J Pharm 77: 279–285

    Google Scholar 

  24. Dorr RT, Fritz WL (1980) Drug data sheets: Bleomycin sulfate. In: Dorr RT, Fritz WL (eds) Cancer chemotherapy handbook. Elsevier, New York, pp 274–283

    Google Scholar 

  25. Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J (1986) Methotrexate in infusion solutions — stability test for the hospital pharmacy. J Clin Hosp Pharm 11: 343–348

    Google Scholar 

  26. Hansen J, Kreilgard B, Nielson O, Vege J (1983) Kinetics of degradation of methotrexate in aqueous solution. Int J Pharm 16: 141

    Google Scholar 

  27. Holthuis JJM, Kettens-vandenBosh, Bult A (1989) Etoposide. In: Florey K (ed) Analytical profiles of drug substances. vol 18. Academic Press, New York, pp 121–151

    Google Scholar 

  28. Horton JK, Stevens MFG (1981) A new light on the photodecomposition of the antitumour drug DTIC. J Pharm Pharmacol 33: 808–811

    Google Scholar 

  29. Humphreys A, Marty JJ, Gooey SL, Bourne DWF (1978) Stability of methotrexate in an intravenous fluid. Aust J Hosp Pharm 8: 66–67

    Google Scholar 

  30. Keller JH, Ensminger WD (1982) Stability of cancer chemotherapeutic agents in a totally implantable drug delivery system. Am J Hosp Pharm 39: 1321–1323

    Google Scholar 

  31. Koberda M, Zieske PA, Raghavan NV, Payton RJ (1990) Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers. Am J Hosp Pharm 47: 2528–2529

    Google Scholar 

  32. Lokich J, Anderson N, Bern M, Wallach S, Moore C, Williams D Umprayn V (1988) Combined floxuridine and cisplatin in a fourteen day infusion. Cancer 62: 2309–2312

    Google Scholar 

  33. Lokich J, Anderson N, Bern M, Wallach S, Moore C, Williams D (1989) Etoposide admixed with cisplatin. Cancer 63: 818–821

    Google Scholar 

  34. Lokich J, Bern M, Anderson N, Wallach S, Moore C, Beauchamp K, Williams D (1989) Cyclophosphamide methotrexate, and 5-fluorouracil in a three drug admixture. Cancer 63: 822–824

    Google Scholar 

  35. Mariani EP, Southard BJ, Woolever JT, Erlich RH, Granatek AP (1980) Physical compatibility and chemical stability of cisplatin in various diluents and in large volume parenteral solutions. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin, Current status and new developments. 1st edn. Academic Press, New York, pp 305–316

    Google Scholar 

  36. McElnay JC, Elliott DS, Cartwright-Shamoon J, D'Arcy PF (1988) Stability of methotrexate and vinblastine in burette administration sets. Int J Pharm 47: 239–243

    Google Scholar 

  37. Pont LO, Cheung APK, Lin P (1979) Calcium leucovorin. In: Florey K (ed) Analytical profiles of drug substances, vol 8. Academic press, New York, pp 315–350

    Google Scholar 

  38. Poochikian GK, Cradock JC, Flora KP (1981) Stability of anthracycline agents in four infusion fluids. Am J Hosp Pharm 38: 483–486

    Google Scholar 

  39. Radford JA, Margison JM, Swindell R, Lind MJ, Wilkinson PM, Thatcher N (1990) The stability of ifosfamide in aqeous solution and its suitability for continuous 7-day infusion by ambulatory pumps. Cancer Chemother Pharmacol 26: 144–146

    Google Scholar 

  40. Reynolds DL, Sternson LA, Repta AJ (1981) Clinical analysis for the antineoplastic agent, 1,4-dihydroxy-5,8-bis-2-[(2-hydroxyethyl)-amino]-9,10-anthracenedione in plasma. J Chromatogr 222: 225–230

    Google Scholar 

  41. Riley CM, Sternson LA (1989) Cisplatin. In: Florey K (ed) Analytical profiles of drug substances, vol 14. Academic Press, New York, pp 77–105

    Google Scholar 

  42. Seargeant L, Kobrinsky NL, Sus CJ, Nazeravich DR (1987) In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide. Cancer Treat Rep 71: 1189–1193

    Google Scholar 

  43. Sewell GJ, Riley CM, Rowland CG (1987) The stability of carboplatin in ambulatory continuous infusion regimes. J Clin Pharm Ther 12: 427–432

    Google Scholar 

  44. Smith JA, Morris A, Duafala ME, Bertino JR, Markman M, Kleinberg M (1989) Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration. Am J Hosp Pharm 46: 985–989

    Google Scholar 

  45. Stella VJ (1987) Chemical and physical bases determining the instability and incompatibility of formulatd injectable drugs. J Parenter Sci Technol 40: 142–163

    Google Scholar 

  46. Stewart CF, Hampton EM (1989) Stability of cisplatin and etoposide in intravenous admixtures. Am J Hosp Pharm 46: 1400–1404

    Google Scholar 

  47. Stewart CF, Fleming R (1990) Compatibility of cisplatin and 5-fluorouracil in 0.9% sodium chloride injection. Am J Hosp Pharm 47: 1373–1377

    Google Scholar 

  48. Tavoloni N, Guarino AM, Berk PD (1980) Photolytic degradation of Adriamycin. J Pharm Pharmacol 32: 860–862

    Google Scholar 

  49. Tomlinson E, Malspeis L (1982) Concomitant adsorption and stability of anthracycline antibiotics. J Pharm Sci 72: 1121–1125

    Google Scholar 

  50. Trissel LA, Kleinman LM, Cradock JC, Davignon JP (1979) Investigational drug information: ifosfamide. Drug Intell Clin Pharm 13: 340–341

    Google Scholar 

  51. Trissel LA, Flora KP, Vishnuvajjala BR, Davignon JP, Quinn FR (1990) NCI Investigational drugs: Pharmaceutical data 1990. National Institutes of Health, Bethesda, Maryland

    Google Scholar 

  52. Trissel LA (1990) Handbook on injectable drugs, 6th edn. American Society of Hospital Pharmacy, Bethesda, Maryland

    Google Scholar 

  53. Vendrig DEMM, Smeets BPGM, Beijnen JH, Houwen OAGJ van der, Holthuis JJM (1988) Degradation kinetics of vinblastine sulphate in aqueous solutions. Int J Pharm 43: 131–138

    Google Scholar 

  54. Vendrig DEMM, Beijnen JH, Houwen OAGJ van der, Holthuis JJM (1989) Degradation kinetics of vincristine sulphate and vindesine sulphate in aqueous solutions. Int J Pharm 50: 189–196

    Google Scholar 

  55. Vincke BJ, Verstraeten AE, El Eini DID, McCarthy TM (1989) Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers. Int J Pharm 54: 181–185

    Google Scholar 

  56. Walker SE, Lau DWC, DeAngelis C, Iazzetta J, Coons C (1980) Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 43: 265–271

    Google Scholar 

  57. Walker SE, Lau DWC, DeAngelis C, Iazzetta J, Coons C (1991) Mitoxantrone stability in syringes and glass vials and evaluation of chemical contamination. Can J Hosp Pharm 44: 143–148

    Google Scholar 

  58. Williams DA (1990) Stability and compatibility of admixtures of antineoplastic drugs. In: Lokich J (ed) Cancer Chemotherapy by infusion, 2nd edn. Precept, Chicago, 7

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, D.A., Lokich, J. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions. Cancer Chemother. Pharmacol. 31, 171–181 (1992). https://doi.org/10.1007/BF00685544

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685544

Keywords

Navigation